Shaping up interestinglyOrder of relevant events:1. DTZ ann...

Shaping up interestingly

Order of relevant events:
1. DTZ ann partnership with cannabis producer Seach Medical, an Israeli based firm, to develop global in-plant cannabis tagging - 8 July 2019 (https://www.asx.com.au/asxpdf/20190708/pdf/446g6nl83pnd3b.pdf)
2. DTZ ann partnership, with Slalom Capital Inc, a Canadian entity focusing on commercialisingcannabis-related solutions with the view to grant Slalom exclusive rights to sell BioDotz in Canada pending sales targets - 15 August 2019 (https://www.asx.com.au/asxpdf/20190815/pdf/447hlbw3clxbg0.pdf)
3. DTZ authenticates cannabis in world-first in-plant track-and-trace through partnership with Seach Medical - 19 September 2019 (https://www.asx.com.au/asxpdf/20190919/pdf/448npjl6gpkpm9.pdf)

So my read through - we have a viable product, proven and accepted by an individual firm.

To be seen:
1. Whether Seach Medical will properly validate the product with an order and therefore $$s - until then, its really just a nice thumbs up but not a lot more
2. Whether Slalom will be able to translate this proof of concept into the Canadian market and actually convert to sales.

Nice to know that it works, but until its validated by orders our situation hasn't changed a lot from July